PHARMACY PRACTICE AND THERAPEUTICS C (PSYCHIATRY AND NEUROLOGY)

PHA3THC

2020

Credit points: 15

Subject outline

This subject investigates the brain. Ultimately, behaviour is the outcome of cellular and molecular processes within the brain, and subtle changes in brain physiology will result in spectacular and often debilitating behavioural pathologies. Therapeutic intervention based on psychotropic drugs aims to restore or tweak brain physiology - while conceptually a sound approach, our understanding of how neurophysiology ultimately is expressed in behaviour, is limited. As a consequence, this subject will not provide you with answers, but aims to enable you to critically appraise therapeutic intervention. In addition, the pharmacy practice issues relating to neuropsychiatry will be addressed in a manner that highlights how psychotropic drugs can ameliorate the various disease states, and how they affect the overall condition of the patient.

School: Molecular Sciences (Pre 2022)

Credit points: 15

Subject Co-ordinator: Christine Kettle

Available to Study Abroad/Exchange Students: Yes

Subject year level: Year Level 3 - UG

Exchange Students: No

Available as Elective: No

Learning Activities: N/A

Capstone subject: No

Subject particulars

Subject rules

Prerequisites: PHA2THA and must be admitted in the Bachelor of Pharmacy Honours (SHPB)

Co-requisites: N/A

Incompatible subjects: N/A

Equivalent subjects: PHA3PGD

Quota Management Strategy: N/A

Quota-conditions or rules: N/A

Special conditions: N/A

Minimum credit point requirement: N/A

Assumed knowledge: N/A

Learning resources

Pharmacology

Resource Type: Book

Resource Requirement: Prescribed

Author: Rang, HP et al.

Year: 2012

Edition/Volume: 7TH EDITION

Publisher: CHURCHILL LIVINGSTONE, EDINBURGH

ISBN: N/A

Chapter/article title: N/A

Chapter/issue: N/A

URL: N/A

Other description: N/A

Source location: N/A

Therapeutic Guidelines: Neurology, Psychotropic, Analgesic

Resource Type: Book

Resource Requirement: Recommended

Author: Therapeutic Guidelines Ltd

Year: N/A

Edition/Volume: N/A

Publisher: LATEST VERSION, THERAPEUTIC GUIDELINES LIMITED, NORTH MELBOURNE

ISBN: N/A

Chapter/article title: N/A

Chapter/issue: N/A

URL: N/A

Other description: N/A

Source location: N/A

Essential Psychopharmacology

Resource Type: Book

Resource Requirement: Recommended

Author: Stahl, SM

Year: 2008

Edition/Volume: 3RD EDITION

Publisher: CAMBRIDGE UP

ISBN: N/A

Chapter/article title: N/A

Chapter/issue: N/A

URL: N/A

Other description: N/A

Source location: N/A

Goodman & Gilman's Manual of Pharmacology and Therapeutics

Resource Type: Book

Resource Requirement: Recommended

Author: Brunton, L & Parker, K

Year: 2006

Edition/Volume: soft cover portable volume

Publisher: MCGRAW-HILL

ISBN: N/A

Chapter/article title: N/A

Chapter/issue: N/A

URL: N/A

Other description: N/A

Source location: N/A

Australian Medicines Handbook.

Resource Type: Book

Resource Requirement: Recommended

Author: Rossi, R

Year: 2009

Edition/Volume: N/A

Publisher: ADELAIDE: AUSTRALIAN MEDICINES HANDBOOK PTY LTD.

ISBN: N/A

Chapter/article title: N/A

Chapter/issue: N/A

URL: N/A

Other description: N/A

Source location: N/A

Career Ready

Career-focused: No

Work-based learning: No

Self sourced or Uni sourced: N/A

Entire subject or partial subject: N/A

Total hours/days required: N/A

Location of WBL activity (region): N/A

WBL addtional requirements: N/A

Graduate capabilities & intended learning outcomes

Graduate Capabilities

Intended Learning Outcomes

01. Explain the role of neurotransmitter systems in the operation of the central nervous system

02. Relate the relevant class of drugs to activity at the molecular level, specifically effect on relevant receptors and other regulatory molecules and processes.

03. Describe and explain the relationship between drug actions and therapeutic outcomes, specifically in the amelioration of clinical conditions related to the central nervous system.

04. Describe the absorption, elimination and metabolism of cardiovascular and respiratory drugs and relate this to clinical practice and how pharmacogenetics affects this.

05. Anticipate and rationalize interaction between drugs (including over-the-counter (OTC preparations)

06. Follow guidelines to critically assess drug use and disease states in a defined case study scenario.

07. Initiate appropriate procedures for mental health first aid

Bendigo, 2020, Semester 2, Day

Overview

Online enrolment: Yes

Maximum enrolment size: N/A

Enrolment information: N/A

Subject Instance Co-ordinator: Christine Kettle

Class requirements

LectureWeek: 31 - 43
Three 1.00 hour lecture per week on weekdays during the day from week 31 to week 43 and delivered via face-to-face.

PracticalWeek: 32 - 34
One 3.00 hours practical per week on weekdays during the day from week 32 to week 34 and delivered via face-to-face.

WorkShopWeek: 31 - 43
One 2.00 hours workshop per week on weekdays during the day from week 31 to week 43 and delivered via face-to-face.

Assessments

Assessment element	Comments	Category	Contribution	Hurdle	%	ILO*
2 oral presentations (1 group and 1 individual) (750 word equivalent total)	N/A	N/A	N/A	No	20	SILO2, SILO3, SILO4, SILO5, SILO6, SILO7
Case study (1000 word equivalent)	N/A	N/A	N/A	No	20	SILO1, SILO2, SILO3, SILO4, SILO5, SILO7
Online quiz and mental health activities (500 word equivalent)	N/A	N/A	N/A	No	10	SILO1, SILO2, SILO3, SILO5, SILO7
One 2-hour written examination	N/A	N/A	N/A	No	50	SILO1, SILO2, SILO4, SILO6, SILO7